Antiretrovirals

For more information, visit the Antiretrovirals Page of the HIV/AIDS Unit of the Pan American Health Organization.

   Other Resources


Other Resources

Tratamiento antirretroviral de la infección por el VIH en adultos y adolescentes en Latinoamérica y el Caribe: en la ruta hacia el acceso universal. Recomendaciones para un enfoque de salud pública. Versión 2007
Reconociendo el extraordinario valor de la Guía de la Organización Mundial de la Salud titulada Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach. 2006 revision como herramienta de referencia para el avance hacia el acceso universal a prevención, la OPS ha querido aprovechar estos esfuerzos y adaptar la guía al contexto latino americano y caribeño para apoyar la estandarización de la atención médica y de tratamiento antiretroviral. Esta guía viene a apoyar el desarrollo de directrices nacionales basadas en evidencia científica.(5/Oct/2007)
en español     PDF(5502.2k)  

Reunión Centroamericana Sobre Atención Integral Y Acceso A Los Antiretrovirales
Reunión Centroamericana Sobre Atención Integral Y Acceso A Los Antiretrovirales San José, Costa Rica 27 y 28 de agosto de 2004(28/Sep/2005)
en español     PDF(609.38k)  

Documento de Bases
ARV-Documento de Bases, Documento de Bases(12/Aug/2005)
en español     PDF(272.86k)  

Second round price negotiation english press release
ARV-Second round price negotiation english press release(12/Aug/2005)
In English       PDF(1172.86k)  
en español     PDF(1172.57k)  

Acuerdo
ARV-Acuerdo, acuerdo(12/Aug/2005)
en español     PDF(681.26k)  

ART (ANTIRETROVIRAL THERAPY) COVERAGE IN THE REGION OF THE AMERICAS (JUNE 2005)
ART(ANTIRETROVIRAL THERAPY) COVERAGE IN THE REGION OF THE AMERICAS (JUNE 2005)(30/Jun/2005)
In English       PDF(174.91k)  

Antiretrovirals: Efforts of Latin America and the Caribbean toward the universal access
Access to antiretrovirals (ARV), the drugs used to kill or inhibit the multiplication of the HIV, is a global priority. But treatment is not yet reaching most of people in need. This page contains information about the Latin America and Caribbean efforts to expand access to antiretrovirals. Among the highlights are the three subregional negotiations (Caribbean, Central America and 10 Latin American countries), in which the ministries of health, with the support of PAHO and other organizations, managed to substantially reduce the price of these medicines. In addition, this page provides several tools useful to expand access to ARV, such as protocols, lists of drug manufacturers of acceptable quality, recommendations on procurement and an overview of relevant policies and legislation. (24/Sep/2003)
In English       HTML(22.69k)  
en español     HTML(32.47k)  

Access to HIV/AIDS Drugs and Diagnostics of Acceptable Quality
The objective of the publication is to assess the acceptability in principle of HIV/AIDS drugs for procurement by UN Agencies. The assessment procedure is aimed at identifying products and suppliers meeting WHO standards. Thus, the publication facilitates the procurement of HIV/AIDS related drugs of acceptable quality.(5/Sep/2003)
In English       Word Doc  
en español     Word doc  

Access to HIV/AIDS Drugs and Diagnostics of Acceptable Quality
The objective of the publication is to assess the acceptability in principle of HIV/AIDS drugs for procurement by UN Agencies. The assessment procedure is aimed at identifying products and suppliers meeting WHO standards. Thus, the publication facilitates the procurement of HIV/AIDS related drugs of acceptable quality.(5/Aug/2003)
In English       Word  
en español     Word  

Sources and prices of selected medicines and diagnostics for people living with HIV/AIDS
The objective of this publication is to assess the acceptability in principle of HIV/AIDS drugs for procurement by UN Agencies. The assessment procedure is aimed at identifying products and suppliers meeting WHO standards. Thus, the project facilitates the procurement of HIV/AIDS related drugs of acceptable quality.countries.(2/Jun/2003)
In English       PDF  
en español     PDF  

Untangling the of price reductions: a pricing guide for the purchase of ARVs for developing countries (MSF)
This guide contains elements help buyers in the decision-making process for the purchase of drugs at reasonable prices. It includes the antiretroviral prices offered by originator companies and some generic companies in low- and middle-income countries. It is meant to provide potential buyers with clear verified data. This information is intended for use by government and non-profit procurement agencies, as well as other bulk purchasers of antiretrovirals, including health facilities and non governmental organizations (NGOs).(15/May/2003)
In English       PDF  
en español     PDF  

Cost-containment mechanisms for the essential medicines, including antiretrovirals, in China
This publication is a summary of issues discussed at meetings between the Ministry of Health China and the World Health Organization, in the area of cost containment mechanisms, policies and options to improve access to essential medicines, including antiretrovirals. The report highlights the fact that countries may adopt a variety of methods and policies in cost containment to render essential medicines more affordable to populations and health insurance systems. (13/Dec/2002)
In English       PDF  
en español     PDF  

World Health Organization (WHO) web page on access to antiretrovirals
The World Health Organization (WHO) web page contains several documents and resources aimed at expanding access to antiretroviral drugs.(22/Sep/2002)
In English       WHO  

Scaling Up Antiretroviral Therapy in Resource-Limited Settings (WHO, 2001)
These guidelines are intended to support and facilitate the proper management and scale-up of ART in the years to come by means of a public health approach, the key tenets of which are: 1) scaling up antiretroviral treatment programmes to meet the needs of people living with HIV/AIDS in resource-limited settings; 2)standardization and simplification of ARV regimens to support the efficient implementation of treatment programmes; 3)ensuring that ARV treatment programmes are based on the best scientific evidence, in order to avoid the use of substandard treatment protocols that compromise the outcome of treatment in individual clients and create the potential for the emergence (9/Apr/2001)
In English       PDF  
en español     PDF